People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Other Technology, Pharma, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LiquidX, Inc. | — | Other Technology | Series B | $78.0M | $13.3M | 2018 |
| Elevation Oncology, Inc. | — | Pharma | Series C | $70.5M | $2.0B | 2020 |
| Nexo Therapeutics, Inc. | — | Biotechnology | Series C | $60.0M | $994.9M | 2022 |
Andrew Phillips at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Phillips on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ali Behbahani | 1 | 17 |
| John Connolly | 1 | 14 |
| Michael Kim | 1 | 14 |
| Carlo Rizzuto | 1 | 7 |
| Richard Gaster | 1 | 7 |
| John M. Connolly | 1 | 6 |
| Steven Elms | 1 | 5 |
| Paul Simpson | 1 | 4 |
| Gary Mueller | 1 | 4 |
| Walter McCormack | 1 | 3 |
| Colin Walsh | 1 | 3 |
| Lori Hu | 1 | 3 |
| Michael Caldwell | 1 | 2 |
| German Soto Sanchez | 1 | 2 |
| Timothy Clackson | 1 | 2 |
| Sandeep Arora | 1 | 2 |
| Dominic Capolongo | 1 | 1 |
| Frank DiMarco | 1 | 1 |
| Edmund Reese | 1 | 1 |
| Kristen Michaud | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.